FDA Approved: DEXTROAMPHETAMINE — Original Application (Cranbury Pharmaceuticals, LLC)

View source ↗

Summary

FDA approves Cranbury Pharmaceuticals' original ANDA for dextroamphetamine, a generic stimulant indicated for attention-deficit/hyperactivity disorder and narco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• Dextroamphetamine (Dextroamphetamine)

Snippet

ORIG AP for DEXTROAMPHETAMINE (DEXTROAMPHETAMINE)